CTBP2 and neoplasm: In this report, we have used a cell line derived from a CKP mouse PDAC tumor in which we homozygously deleted the Ctbp2 gene via CRISPR, to further interrogate the oncogenic mechanism of action of Ctbp2 in PDAC progression using an orthotopic allograft PDAC mouse model.